Next Article in Journal
Candida spp. in Cetaceans: Neglected Emerging Challenges in Marine Ecosystems
Next Article in Special Issue
Production of Esters in Escherichia coli Using Citrate Synthase Variants
Previous Article in Journal
Deciphering the Puzzle: Literature Insights on Chlamydia trachomatis-Mediated Tumorigenesis, Paving the Way for Future Research
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Biological Significance of Probiotic Microorganisms from Kefir and Kombucha: A Review

by
Talita Andrade da Anunciação
1,
Juan Diego Silva Guedes
2,
Pedro Paulo Lordelo Guimarães Tavares
1,
Fernando Elias de Melo Borges
3,
Danton Diego Ferreira
3,
Jorge Alberto Vieira Costa
4,
Marcelo Andrés Umsza-Guez
1,* and
Karina Teixeira Magalhães-Guedes
1,*
1
Post-Graduate Program in Food Science, Bromatological Analysis Department, Pharmacy Faculty, Federal University of Bahia (UFBA), Barão of Jeremoabo Street, s/n, Ondina, Salvador 40171-970, BA, Brazil
2
Post-Graduate Program in Industrial Engineering, Polytechnic School, Federal University of Bahia (UFBA), Street Professor Aristídes Novis, 02, Federação, Salvador 40210-630, BA, Brazil
3
Post-Graduate Program in Systems Engineering and Automation, Department of Engineering, Federal University of Lavras (UFLA), University Campus, Lavras 37000-200, MG, Brazil
4
Laboratory of Biochemical Engineering, College of Chemistry and Food Engineering, Federal University of Rio Grande (FURG), Rio Grande 474-96203-900, RS, Brazil
*
Authors to whom correspondence should be addressed.
Microorganisms 2024, 12(6), 1127; https://doi.org/10.3390/microorganisms12061127
Submission received: 23 April 2024 / Revised: 20 May 2024 / Accepted: 28 May 2024 / Published: 31 May 2024

Abstract

:
(1) Background: The human microbiota is essential for maintaining a healthy body. The gut microbiota plays a protective role against pathogenic bacteria. Probiotics are live microorganisms capable of preventing and controlling gastrointestinal and balancing the immune system. They also aid in better nutrients and vitamins absorption. Examples of natural probiotic cultures are kefir and kombucha. (2) Methods: Therefore, the aim of this review was to address the beneficial properties of probiotic kefir and kombucha using a Boxplot analysis to search for scientific data in the online literature up to January 2024: (Latin American and Caribbean Health Sciences (LILACS), PubMed, Medical Literature Analysis (MED-LINE), Science Direct, Google Scholar/Google Academic, Bioline Inter-national and Springer Link). Boxplots showed the summary of a set of data “Index Terms—Keywords” on kefir and kombucha in three languages (English, Portuguese and Spanish). (3) Results: Google Scholar was the database with the highest number of articles found, when the search for the keywords used in the study (containing ~4 × 106–~4 million articles available). This was Followed by the Science Direct database, containing ~3 × 106–~3 million articles available, and the BVS databases—Biblioteca Virtual de Saúde (Virtual Health Library) e Lilacs, both containing a value of ~2 × 106–~2 million articles available. The databases containing the smallest number of articles found were Nutrients and Medline, both containing a value of ≤0.1 × 106–≤100 thousand articles. (4) Conclusions: Scientific studies indicate that kefir and kombucha certainly contain various functional properties, such as antimicrobial, antitumor, anticarcinogenic and immunomodulatory activity, in addition to having a microbiological composition of probiotic bacteria and yeasts. Kefir and kombucha represent key opportunities in the food and clinic/medical fields.

1. Introduction

In recent decades, dietary habits and lifestyle have undergone several changes, leading to an overload on the body’s systems, such as the consumption of processed foods and fast-food, and sedentary behavior. This scenario has prompted people to seek alternatives to improve their health and nutrition [1,2,3,4]. Functional clinical nutrition is a contemporary approach to promoting the science of nutrition, aiming to assess the interaction of the body with food. This is necessary to adequately nourish the body in terms of quantity and quality, providing all the essential nutrients for proper functioning. This is also necessary to ensure good digestion and adequate absorption of ingested nutrients [4,5,6,7].
In addition to a healthy diet, the human microbiota is essential to maintain a balanced body. The human microbiota, especially the gut microbiota, plays a protective role against pathogenic bacteria [3,8].
Dysbiosis is an irregularity in the gut microbial population. This can lead to the development of a chronic inflammatory state. Dysbiosis causes symptoms such as gas, diarrhea, or constipation, and it is also related to cardiovascular diseases, metabolic syndromes, central nervous system disorder and immunological alterations [3,8]. Thus, probiotic foods/beverages are seen as improving both intestinal microbiota and human well-being [3,8].
Probiotics are live microorganisms capable of preventing and controlling gastro-intestinal issues and balancing the immune system [9,10,11,12,13,14]. They also combat allergies, aid in de-toxification, and regulate the body for better nutrient and vitamin absorption [9,10,11,12]. Currently, there is a variety of microorganisms used to produce different probiotic foods, such as lactic acid bacteria, acetic acid bacteria and yeasts [9,10,11,12,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35]. However, this study demonstrates the benefits of natural probiotic cultures in kefir [15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31] and kombucha [32,33,34,35].
Kefir is a fermented beverage produced by the action of lactic acid bacteria, acetic acid bacteria and yeast, which coexist in symbiotic association in kefir grains [15,16,17,18,19,20,21,22]. The large number of probiotic microorganisms present in kefir, the bioactive compounds resulting from microbial metabolism, and the benefits associated with its regular consumption confer on kefir the status of a natural probiotic culture. Studies have shown that kefir and its metabolites have antimicrobial, antitumor, anticarcinogenic and immunomodulatory activity [23,24,25,26,27,28,29,30,31].
Kombucha is a food that has become popular within the current market trends regarding the search for healthier food [32,33,34,35]. Kombucha is an Asian, sweet, fermented beverage made from green tea and/or black tea (Camellia sinensis). Fermentation is caused by a symbiotic association of bacteria and yeast, forming a film called SCOBY (Symbiotic Culture of Bacteria and Yeasts) with a protein and fibrous constitution [32,33,34,35]. SCOBY can also be used as an inoculum for the formulation of fermented probiotic beverages, such as fruit kombucha. Several studies have reported beneficial properties of this fermented beverage, such as antimicrobial, anti-inflammatory, anticancer, antihypertensive, anti-diabetic and hepatoprotective activity [32,33,34,35].
Therefore, the aim of this review was to address the beneficial properties of probiotic kefir and kombucha using a Boxplot to search scientific data in the online literature. For this study, a search was carried out in online databases until January 2024: (Latin American and Caribbean Health Sciences (LILACS), PubMed, Medical Literature Analysis (MEDLINE), Science Direct, Google Scholar/Google Academic, Bioline International and Springer Link). Descriptive statistics were applied to analyze the data found. The descriptive statistics used in this study were via a Boxplot or Box-and-Whisker plot, which is a type of graph used in data intelligence analysis. Intelligent Boxplots visually display the distribution of numerical data and skewness, showing quartiles of data (or percentiles) and means. Boxplots provide a summary of a dataset, including the minimum score, first quartile (lower), median, third (upper) quartile, and maximum score for different “Index Terms—Keywords” [36,37].

2. Methods

For the elaboration of this study, a search was carried out in online databases until January 2024: (Latin American and Caribbean Health Sciences (LILACS), PubMed, Medical Literature Analysis (MEDLINE), Science Direct, Google Scholar/Google Academic, Bioline International and Springer Link). The “Index Terms” used for searches were developed in three languages (English, Portuguese and Spanish). English was used because it is the most common language in scientific articles worldwide. Portuguese is the authors’ native language. Spanish is the most frequently used language in South America, where Brazil is located, the authors’ resident country. Keywords in English = “probiotics microorganisms”, “kefir probiotic”, “symbiotic culture”, “kefiran”, “non-dairy probiotic beverage”, “functional beverage”, “kombucha probiotic”, “functional kombucha beverage” and “functional kefir beverage”. Keywords in Spanish = “microorganismos probióticos”, “kéfir probiótico”, “cultivo simbiótico”, “kefiran”, “bebida probiótica no láctea”, “bebida funcional”, “probiótico kombucha”, “bebida kombucha funcional” and “bebida de kéfir funcional”. Keyword in Portuguese = “micro-organismos probióticos”, “kefir probiótico”, “cultura simbiótica”, “kefiran”, “bebida probiótica não láctea”, “bebida funcional”, “kombucha probiótico”, “bebida funcional de kombucha” and “bebida funcional de kefir”.
Initially, the title/abstract was read, noting the year of publication, methodology used, and main results described. Subsequently, a Boxplot analysis of the data surveyed in the different studied databases was carried out. The data was grouped into 3 groups [36,37]:
  • Repository: this group has 9 clusters, each made up of the repository with its respective number of articles;
  • Language: this group has 3 clusters, each consisting of the idiomatic expression of the papers with the respective number of articles;
  • Keyword: this group has 9 clusters, each made up the keyword of the paper (regardless of the language of the article) with their respective number of articles.
After obtaining the groups, Boxplot analyses were performed. The Boxplot constructs a graphic visualization of the statistical distribution of a variable. A Boxplot is a standardized way of displaying data distribution based on a five number (“minimum”, first quartile (Q1), median, third quartile (Q3), and “maximum”). It can provide information about outliers and what their values are. It can also indicate whether data are symmetric, how tightly data are grouped, and if and how data are skewed.
The edges of the box show the 25th and 75th percentiles, respectively, by the lower and upper edges, and point out if the edges are labelled as outliers. The Boxplot analysis has setting visualization options, one of them being the “Notched Boxplot”, where the user can see the difference in the medians of the variables and the confidence of this difference. If there is no overlap in the notches, then there will be a difference between the medians with 95% confidence [36,37]. Subsequently, all articles were selected by title, abstract and full text, excluding those that did not address subjects related to the main theme of this review.

3. Results

Boxplot Analysis

Application of “Boxplot analysis” for analysis of the data researched in this study (number of articles in relation to languages and databases) was performed as described in the section “Methodology”. The results of these analyzes are described and explained in this section.
In Figure 1, the distribution of number of papers in the groups of keywords used is represented.
Group D—Keywords in English (probiotics microorganisms); in Spanish (microorganismos probióticos); in Portuguese (micro-organismos probióticos) and G group—Keywords in English (kefir probiotic); in Spanish (kéfir probiótico); in Portuguese (kefir probiótico) represent the largest number of articles found found(4 × 106–~4 million articles) in the different searched databases (BVS—Biblioteca Virtual de Saúde (Virtual Health Library), Google Scholar, Springer, Science Direct, Nutrients, Scielo, Medline, Lilacs and PubMed). Followed by F group—Keywords in English (kombucha probiotic); in Spanish (probiótico kombucha); in Portuguese (kobucha probiótico) and H group—Keywords in English (non-dairy probiotic beverage); in Spanish (bebida probiótica no láctea); in Portuguese (bebida probiótica não láctea), containing both ~2 × 106–~2 million articles. B group, Keywords in English/Spanish/Portuguese (kefiran), is the group with the smallest number of articles found at ≤0.1 × 106–≤100 thousand articles.
The Boxplot shows that the terms “probiotics microorganisms—microorganismos probióticos—micro-organismos probióticos” and “kefir probiotic—kéfir probiótico—kéfir probiótico” are the most prevalent “Index Terms” in titles and keywords of scientific articles about kefir. These “Index Terms” characterize “Kefir” in relation to the scientific articles available in the three languages (English, Spanish and Portuguese) (Figure 1).
Figure 2 shows the distribution of number of papers by searched databases (BVS—Biblioteca Virtual de Saúde (Virtual Health Library), Google Scholar, Springer, Science Direct, Nutrients, Scielo, Medline, Lilacs and PubMed).
Google Scholar was the database with the highest number of articles found, when analyzing the search for keywords from all groups (A–I) in Figure 1, containing ~4 × 106–~4 million articles available. This was followed by the Science Direct database, containing ~3 × 106–~3 million articles available, and the BVS databases—Biblioteca Virtual de Saúde (Virtual Health Library) e Lilacs, both containing a value of ~2 × 106–~2 million articles available. The databases with the lowest number of articles found were Nutrients and Medline, both containing a value of ≤0.1 × 106–≤100 thousand articles. The notch of the google scholar database does not intersect the notch of the Springer, Nutrients, Scielo, Medline and Pubmed databases, so it can be said that the mean of the Google Scholar database is different from these with 95% certainty.
The Boxplot shows that the “Google Scholar” database presents the highest number of scientific articles in relation to all “Index Terms” used in the three languages (English, Spanish and Portuguese). The boxplot also considered the “Science Direct” database to be highly relevant for the search for scientific articles (Figure 2).
Figure 3 shows the distribution of number of papers by languages searched (English, Spanish and Portuguese), considering all groups of keywords (A–I) in Figure 1 and the different databases searched in Figure 2 (BVS—Library Virtual Health Library, Google Scholar, Springer, Science Direct, Nutrients, Scielo, Medline, Lilacs and PubMed). The highest number of articles found was in the English language, adding up to ~8 × 106–~8 million available articles. The second-highest number of articles found was in the Portuguese language, adding up to ~0.1 × 106–~100 thousand articles available. The lowest number of articles found was in the Spanish language, adding a value of ≤0.05 × 106–~50 thousand available articles.
The Boxplot shows that the English language is predominant compared to the three languages (English, Spanish and Portuguese). English is also predominant for all “Index Terms” and “Databases” researched in this study. This demonstrates that the English language is considered universal in the scientific community.
Considering the two databases with the highest number of articles found, Google Scholar, followed by Science Direct, in Table 1 and Table 2 can be seen the correlation between the quantitative analysis of scientific articles and the respective database analyzed. We can see the predominance of the English language in relation to the number of available articles (Figure 3).
Regarding the Google Scholar database (Table 1), the highest number of available articles was with the keyword “probiotics microorganisms” (993,000 articles available), followed by “kefir probiotic” (779,000 articles available) and “non-dairy probiotic beverage” (747,600 articles available). Regarding the Science Direct database (Table 2), the highest number of available articles was with the keyword “symbiotic culture” (31,111 articles available), followed by “probiotics microorganisms” (19,184 articles available) and “functional beverage” (6923 articles available). Boxplot analyzes show, the number of articles available in the English language predominant in both databases (Google Scholar and Science Direct). It is also possible to notice that the Science Direct database provides few articles in Spanish and no articles in Portuguese. This reinforces the general prevalence of scientific articles in the English language.
After the quantitative evaluation results from the Boxplot, articles were selected by title, abstract and full text, excluding those that did not address subjects related to the main focus of this review. A total of 83 articles were selected to discuss in this review. Among the 83 selected articles, 82 are in English and 1 in Portuguese.

4. Discussion

4.1. Historical Report for Kefir and Kombucha

The origin of kefir grains predates known records, but the first registers of similar beverages are from the Caucasus [15,16,17,18,19,20,21,22]. In ancient times, the Eastern nomadic shepherds discovered that the milk they carried in their leather purses during their travels would sometimes transform into a foamy beverage. The nomads called the beverage “kefir” and it is believed that the word originates from “keyif” which means “joy/pleasure” in Turkish [15,16,17,18,19,20,21,22]. There is also another legend that the Prophet Muhammad gave kefir grains to the people living in the mountains of the northern Caucasian, and they were then passed from generation to generation until the present day [15,16,17,18,19,20,21,22]. Kefir is also known as kefyr, kephir, kefer, kiaphur, knapon, kepi, and kippi in different countries all over the world [15,16,17,18,19,20,21,22].
Kombucha originates from East Asia. It was known in China for its energizing and detoxifying properties, where this beverage was named “Divine Che” [32,33,34,35]. After China, the popularity spread to Asia. There is a legend about the name: a physician named Kombu used the beverage (tea or “cha” in Japanese) to treat Emperor Inkyo, so the beverage was known as kobu’s tea, kombucha. From Japan, this beverage went to Russia (named “Tea Kvass”) and then spread throughout Europe and Africa. Nowadays, it is well known around the word [32,33,34,35].

4.2. Kefir: Microbiome and Preparation

Kefir is a fermented mildly effervescent beverage. The fermentation process for kefir is conducted by a natural microbiota present in the polysaccharide matrix of kefir [23,24,25,26,27,28,38,39]. Kefir grains are a symbiotic association composed mainly of yeasts, lactic acid bacteria and acetic acid bacteria. Kefir grains range in size from 0.5–3.5 cm in diameter, have an irregular shape, and a yellowish or whitish color [27,28,29,30,31,38,39].
The microbial composition of kefir grains varies according to the region of origin and the substrate used for the proliferation of grains and the techniques used in their manufacture [24,25,26,27,28,29,30]. The main microbial genera found in kefir grains and beverage are shown in Figure 4. There are species from various genera of bacteria and yeasts [24,25,26,27,28,29,30,38,39].
Tavares et al. [39] evaluated kefir microbial diversity during the fermentation process by PCR–DGGE (Polymerase chain reaction denaturing gradient gel electrophoresis) molecular method and microbial species-level sequencing. Microbial diversity was distributed in four bacterial genera and four yeast genera. Bacteria from the genera Lactobacillus, Lacticaseibacillus, Lentilactobacillus, Leuconostoc, and Acetobacter were found, along with the yeasts Saccharomyces, Kluvyeromyces, Lachancea, and Kazachstania.
Kefir grains are capable of fermenting on various substrates, such as cow, goat, sheep, and buffalo milk, brown sugar, fruit juices, soy extract, vegetables, and cereals [27,28,29,38,39]. The microbial species in kefir grains undergo three types of fermentation during the process: lactic, alcoholic, and acetic. This aspect, along with the adaptability of the grains, as described above, reflects the potential for new formulations and beverages [27,28,29,38,39]. The “traditional” way to produce kefir beverage is to use pasteurized or UHT (ultra-high-temperature processing) treated milk or brown sugar solution. However, other substrates can be used in the kefir grain fermentation process, such as soy/cereal extracts and fruit/vegetable pulp (Figure 5). After fermentation for 24–48 h, kefir beverage is ready to be consumed [27,28,29,38,39] (Figure 5).

4.3. Kombucha: Microbiome and Preparation

Kombucha is a fermented beverage produced by the fermentation of black, oolong or green tea, varieties of Camellia sinensis tea, with sugar and a symbiotic microorganism culture known as SCOBY (Symbiotic Culture of Bacteria and Yeast) (Figure 6).
Many microorganisms are isolated from SCOBY, including acetic acid bacteria (Acetobacter spp., Gluconobacter spp. and Komagataeibacter spp.), lactic acid bacteria (Lactococcus spp. and Lactobacillus spp.) and yeasts (Brettanomyces spp., Kloeckera spp., Saccharomyces spp., Saccharomycodes spp., Schizosaccharomyces spp., Torulaspora spp., and Zygosaccharomyces spp.). The diversity of microorganisms with probiotic potential interacting with each other and with liquid environment is the reason for the beneficial properties of the beverage produced [40,41,42,43,44].
This kombucha beverage is fermented for a period of 7–12 days at room temperature in static fermentation (Figure 7). The organoleptic characteristics of the final beverage are modified based on the production environment, mainly temperature and the fermentation time. It is also important to add that the microorganisms from that beverage are distributed in two categories: those which are part of the cellulose biofilm and others which are struggling in the liquid [33,34].

4.4. Functional Properties of Kefir: Immunomodulatory, Antitumor/Anticarcinogenic, and Antimicrobial Activity

4.4.1. Kefir Probiotic Microorganisms in Immunomodulatory Activity

Studies on the action of probiotic microorganisms on the host immune system have been carried out for some time [1,2,3,4,5,6,7,8,9,10,11,12,13,14,27,28,29,30,31]. Recent and non-recent bibliographies, most reporting studies with lactic acid bacteria, have shown that probiotics have an immunostimulant effect in animals and humans, although the mechanisms by which this occurs are not yet fully understood [1,2,3,4,5,6,7,8,9,10,11,12,13,14].
The immunostimulant effect may be related to the probiotic microorganism’s ability to interact with Peyer plaques and intestinal epithelial cells, stimulating IgA-producing B cells and migration of T cells from the gut [10]. The regular use of probiotics increases the macrophage phagocytic activity, stimulating the immune system [10].
Different strains of Lactobacillus, such as Lactobacilli, can be used in immunotherapeutic applications like oral vaccination therapy to induce T cell tolerance against autoimmune diseases [8]. Oral administration of Lactobacillus reuteri and Lactobacillus brevis has been shown to induce the expression of pro-inflammatory cytokines [8]. Consumption of the selected Lactobacillus strain provides a strategy to influence cytokine expression and generate an immune response in the human body, improving the host immune system [8].

4.4.2. Kefir Probiotic Microorganisms with Antitumor/Anticarcinogenic Activity

Studies have been conducted using experimental mice or in vitro indicating some success in tumor size reduction with consumption of kefir beverage and grains. In the first report, an investigation of the antitumor effects of a water-soluble polysaccharide isolated from kefir grains indicates that the polysaccharide was able to inhibit the growth of Ehrlich carcinoma compared to control mice [45,46,47]. Furukawa et al. The authors of [48] indicated that feeding with kefir grain (2 g/kg body weight) was more effective in tumor inhibition (Lewis lung carcinoma) when administered 9 days after tumor inoculation in mice. Another study focused on the effects of oral administration of cow’s milk and kefir beverages (soy and milk) on tumor growth in mice inoculated with sarcoma-180 tumor cells resulting in ~65% and ~71% tumor growth inhibition, respectively, compared to controls [47].
Reis et al. [46] evaluated the effect of regular consumption of milk kefir beverage on the development of pre-neoplastic colonic lesions. Thirty Wistar rats were given water (Control group) or milk (Milk group) or kefir beverage (Kefir group) for five weeks. After that, colonic lesions were chemically induced, and the treatments continued for an additional thirteen weeks. Regular consumption of kefir beverage was able to reduce the incidence of aberrant crypt foci by 36%. The consumption of kefir beverage also increased the cecal concentration of short chain fatty acids, reduced the lactulose/mannitol ratio, and promoted an increase in the colonic concentration of TNF-α and IL-1β, and the enzyme catalase in comparison with the control group. Thus, milk kefir beverage reduced the development of lesions, probably by increasing the production of short chain fatty acids, with reduction of intestinal permeability, immunomodulation and improvement of colonic antioxidant activity.

4.4.3. Kefir Probiotic Microorganisms with Antimicrobial Activity

The main probiotic effect of kefir is its ability to modulate the host gut microbiota, where there is a reduction in undesirable microorganisms and an increase in the number of beneficial microorganisms, such as Lactobacillus spp. and Bifidobacterium spp. [12,14,39,49,50,51]. Antimicrobial substances in kefir, such as lactic acid, acetic acid and H2O2, have been reported to have bactericidal and bacteriostatic effects on bacterial pathogens [12,14,39,49,50,51]. Lactic acid reduces the pH of the gastrointestinal tract, which is not suitable for the growth of pathogens [12,14,39,49,50,51]. In addition, H2O2 has an antagonistic and acetic acid has an antibacterial effect on pathogens [50]. Salmonella spp., Yersinia spp., Shigella spp., Micrococcus spp., Escherichia coli, Bacillus cereus, Candida albicans and Klebsiella pneumoniae are some of the pathogenic microorganisms inhibited by kefir [50]. In research that focused on the undesirable microbial inhibition activity of kefir, Staphylococcus aureus, Pseudomonas fluorescens, Escherichia coli and Bacillus subtilis were used as the target microorganisms, which are known to promote gastrointestinal diseases such as diarrhea. According to the results of the research, kefir showed microbial inhibition activity against all the target microorganisms [52].
There are many other studies that show the antibacterial activity of kefir and kefir grains against various pathogen bacteria and yeasts such as Salmonella spp., Shigella spp., Staphylococcus spp., Pseudomonas spp., Bacillus spp., Streptococcus pp., Yersinia spp. and Micrococcus spp. [53,54,55]. Kefir and its insoluble polysaccharide, kefiran, were both tested for antimicrobial activity against different bacterial species using an agar diffusion method. Both kefir and kefiran showed some activity against all tested pathogenic microorganisms; the highest activity was against Streptococcus pyogenes [53,54,55].

4.5. Functional Properties of Kombucha: Immunomodulatory, Antitumor/Anticarcinogenic, and Antimicrobial Activity

4.5.1. Kombucha Probiotic with Immunomodulatory Activity

There are many recent studies on kombucha and its immunomodulatory activity. Zubaidah et al. [56] compared black tea kombucha and Arabica coffee leaves tea kombucha in terms of their immunomodulatory activity in mice infected with Salmonella typhi. They found that black tea kombucha was suitable for use as an immunomodulatory agent in mice infected with S. typhi. This result must be related to the composition of phenolic compounds and organic acids present in the beverage.
Sknepnek et al. [57] examined the possibility of using medicinal mushrooms for the development of new kombucha products, to increase their consumption. The products created were mushrooms’ fruiting bodies and 10% (v/v) actively fermenting black tea (Camellia sinensis L.) kombucha broth. Sknepnek et al. [57] also analyzed the biological properties of kombucha polysaccharides, finding highly desirable immunomodulatory properties in human cell cultures. The results obtained regarding the inhibitory effects of kombucha extracts on Th2 and IL-10 suggest that the consumption of kombucha beverages prepared on edible mushroom substrates, as well as the consumption of isolated polysaccharide extracts, may be beneficial for the prevention and treatment of Th2-mediated immunopathology, such as allergic reactions, asthma or atopic dermatitis. In addition, the stimulation of pro-inflammatory cytokines and reduction of anti-inflammatory IL-10 cytokine after treatment of PHA-stimulated PBMCs with kombucha mushroom polysaccharide extracts may contribute to the body’s defense potential against external pathogens, such as viruses. Further studies are needed to confirm these findings; however, the results suggest that the consumption of kombucha may hold promise for improving the immune response of the human body.
In another study, the objective was to investigate the antioxidant activity and anti-inflammatory effects of Kombucha produced with oak (KAO), by examining its ability to modulate in TNF-alpha and IL-6 derived from macrophages. Among the results, the levels of pro-inflammatory cytokines IL-6 and TNF-alpha were significantly reduced by the sample treatment. Likewise, the nitric oxide (NO) production was lower in the treatment with kombucha, and KAO compared to LPS-stimulated macrophages. Fermented oak beverages negatively regulated NO production, while pro-inflammatory cytokines (TNF-alpha and IL-6) in macrophages were stimulated with LPS. In addition, the phytochemicals present in KAO decrease oxidative stress [58].

4.5.2. Kombucha Probiotic with Antitumor/Anticarcinogenic Activity

There are several studies on the anticarcinogenic potential of kombucha [59,60,61]. Ziska et al. [59] investigated the cytotoxic activity of Solanum nigrum L. n-hexane fruit extract against MCF-7 breast cancer cell line. In this study, two fermentations were carried out with kombucha and then 20% (v/v) of the previous beverage was added as inoculum for fermentation of the extract, with addition of 1.5% (w/v) n-hexane fruit extract, and 20% (w/v) white sugar. Among the interesting results found in this study, flavonoids and steroids were identified from the extract and GC–MS. However, the cytotoxic activity did not show significant results for the MCF-7 breast cancer cell line.
In contrast, promising results were found in a study conducted by Ghodousi Dehnavi et al. [60] which evaluated the effect of different fractions of Kombucha tea on the proliferation and apoptosis of the HT-29 colon cancer strain, yielding promising results. The findings revealed that the cell growth inhibition was dose dependent. The IC50 concentration in these fractions caused DNA fragmentation. In this study, cell death occurred via the apoptotic pathway and showed anti-proliferative activity. This demonstrated that kombucha can be a good candidate for inhibiting the proliferation of colorectal cancer cells.
Another study aimed to investigate the cytotoxicity of kombucha obtained from samples of different teas against the colorectal cancer cell line and found promising results. Kombucha tea was prepared with 1% green tea, oolong tea or black tea and 10% sucrose with the initial culture of kombucha tea: a consortium culture combining yeast and acetic acid bacteria. Kombucha prepared from green tea and black tea demonstrated toxicity in colorectal cancer cells Caco-2 [61].

4.5.3. Kombucha Probiotic with Antimicrobial Activity

The antimicrobial properties of kombucha have been studied in different conditions and for different applications, from food to environmental settings. Kombucha production is a homemade culture, so the kombucha environment is not sterile. However, over the years, several researchers studying different kombucha colonies have not found a high contamination of the colonies with other microorganisms to be pathogenic. In addition to the symbiotic/probiotic culture having antimicrobial potential, the high acidity and alcohol content influence the absence of contaminants [62].
In a recent study, Laurenson et al. [63] tested the effectiveness of Kombucha SCOBY (symbiotic culture of bacteria and yeast) in reducing the concentration of Escherichia coli in dairy effluent shed (SDR). In this study, the SCOBY kombucha was highly effective in reducing the number of E. coli colony forming units (CFU) to undetectable levels. The decrease in CFUs occurred within 48 h after inoculation of the Kombucha SCOBY into the effluent matrix, and there was also a significant decrease in the pH of this effluent.
Santos Júnior et al. [64], seeking to analyze the consumption of fermented kombucha conducted in a Brazilian hospital, provided important results on the beverage’s antimicrobial activity. The fermented growth was efficient against Microsporum canis (LM-828), Escherichia coli (CCT-0355) and Salmonella typhi (CCT-1511). The best inhibition conditions against M. canis (>32 mm) and E. coli (16 mm) were observed at pH 4.0, 55% commercial sugar and 0.10 g/L MgSO4, and for S. typhi (32 mm) without MgSO4.
Battikh et al. [65], aiming to compare the antimicrobial activities of two kombucha beverages fermented from green and black teas and to characterize the antimicrobial compounds, found interesting results for antifungal and antibacterial response. The results showed interesting antimicrobial potentials of both kombucha teas tested against the tested microorganisms, except Candida krusei. Fermented green tea exhibited the highest antimicrobial potential, against Staphylococcus epidermidis, Listeria monocytogenes and Micrococcus luteus. In addition, an interesting anti-Candida potential was revealed by the reaction of green tea kombucha against Candida parapsilosis.
Another study by Kaewkod et al. [61] investigates the antioxidant and antibacterial properties of kombucha obtained from different types of C. sinensis, including green tea, oolong tea, and black tea. They found that pathogenic enteric bacteria: Escherichia coli. E. coli O157: H7, Shigella dysenteriae, Salmonella typhi, and Vibrio cholera were inhibited by kombucha.

4.6. Technological Advances for Improving Kefir and Kombucha Functional Properties

Atalar and Dervisoglu [66] utilized a methodology based on the optimization of the parameters of the spray drying process of kefir powder using response surface methodology (RSM). This study proposes an alternative production of kefir. This could bring benefits for those seeking simple and quick consumption at home without having to grow the grains. The optimum spray drying conditions were combined with the lyophilization results. The findings showed that, at the ideal point, high quality kefir could be obtained as lyophilized powder. Teijeiro et al. [67] also evaluated the suitability of producing kefir powder using spray drying. The authors assessed the survival of microorganisms after drying, storage and simulated gastrointestinal conditions. The results demonstrated that spray drying of kefir is an appropriate approach to obtaining a concentrated and efficient product. Spray drying of kefir leads to many advantages for storage and transportation, in addition to containing viable and active microorganisms.
Yilmaz et al. [68] studied an alternative way of encapsulating probiotics within alginate nanofibers by electrospinning, monitored under simulated gastrointestinal conditions. Probiotic viability was determined under simulated gastrointestinal and in vitro conditions. Nanoencapsulation of the Lactobacillus paracasei KS-199 strain isolated from kefir could increase its survival in simulated gastric juice and improved its viability/survival in the gut. Given the results, it was possible to suggest that alginate could be an important biopolymer playing an essential role in probiotics encapsulation for greater viability. Nano-encapsulated Lactobacillus paracasei KS-199 strain demonstrated higher survival during its passage through the stomach and colonization of the gut.
Jayabalan et al. [69] studied heat treatments to test the long-term storage of kombucha and prevent biofilm formation in the final product. The study revealed the influence of heat on the biochemical constituents and free radical scavenging properties of kombucha tea. The heat treatment at 60, 65 and 68 °C for 1 min controlled biofilm formation in kombucha tea without changing its clarity and flavor. However, polyphenols in the tea and the quality parameters of black tea varied during the storage period. It was concluded that heat treatment was not an adequate method for preserving kombucha tea.
Roby et al. [70] carried out a study with the objective of producing fermented dough bread using an encapsulated kombucha starter culture without the addition of baker’s yeast. Principal component analyzes showed the presence of 15 metabolites in the kombucha fermented dough. The main compounds contributing to differences in sourdough yeast without kombucha were alpha-aminobutyric acid, alanine, acetic acid, riboflavin, pyridoxine, anserine, tryptophan, gluconic acid and trehalose. The encapsulated kombucha yeast starter increased the volume of the bread compared to the yeast bread. The kombucha as an encapsulated fermented dough starter extended the life of the bread by 5 to 10 days at room temperature. Dough bread prepared using the encapsulated kombucha dough initiator showed higher flavor scores and overall acceptability compared to the other bread. The findings indicate that the encapsulated kombucha yeast starter promises to produce functional yeast dough bread with extended shelf life and improved quality.

4.7. An Informed Opinion and Manuscript Limitation

Kefir and kombucha are functional foods with several therapeutic benefits, as described throughout this review: Kefir and Kombucha possesses anti-inflammatory activity, antibacterial activity, anticarcinogenic potential, antimicrobial activity, antioxidant activity, activities against mental disorders and anti-proliferative activity, which have currently been studied. However, most of the health benefits are not scientifically proven in human clinical models. Future studies hold promise in scientifically demonstrating the claimed health benefits.
Despite the benefits, there are some limitations to kefir and kombucha consumption. Consumption of these cultures can be harmful only if they are incorrectly prepared and if individuals with preexisting conditions prove intolerant to the characteristics of the fermentative process of kefir and kombucha. As these cultures contain acetic acid and lactic acid, they possess an acidic pH, which can be limiting for some individuals with stomach disorders. However, research on the stomach, skin, lactose intolerance, hyperlipidemia, and sensorimotor behavior is continuously increasing.
Regarding safety for consumption, the main reasons for culture contamination include unreliable raw materials, vessels, packages, and a lack of sanitation during the fermentation process. This can lead to exposure to undesirable metabolites and microorganisms. Therefore, some protocols and standards should be framed by health organizations to standardize production methods, raw materials, and quality control. At the same time, limitations regarding this study are also noted regarding the databases and languages Other scientific databases can be used worldwide by students, teachers/researchers, and professionals. However, the databases investigated in this study cover the available global literature. In relation to the three languages (English, Portuguese and Spanish), there is a limitation in relation to different countries. The authors chose English, Portuguese and Spanish, as they are used in their countries of residence. However, the English language is considered universal in terms of globally reaching scientific publications.

5. Conclusions and Prospects

The boxplots analysis revealed a summary of a dataset “Index Terms—Keywords” for kefir and kombucha. Google Scholar was the database with the highest number of articles found, when the search for the keywords used in the study (containing ~4 × 106–~4 million articles available). Following Google Scholar was the Science Direct database, containing ~3 × 106–~3 million articles available, and the BVS databases—Biblioteca Virtual de Saúde (Virtual Health Library) and Lilacs, both containing a value of ~2 × 106–~2 million articles available. The databases containing the lowest number of articles found were Nutrients and Medline, both with a value of ≤0.1 × 106–≤100 thousand articles.
Kefir and kombucha have been known as complex probiotic cultures for centuries, as they have unique chemical and microbiological compositions. Many scientific studies indicate that kefir and kombucha certainly contain various functional properties, such as antimicrobial, antitumor, anticarcinogenic and immunomodulatory activity, in addition to having a microbiological composition of probiotic bacteria and yeasts. These fermented probiotic cultures have great probiotic/functional potential of scientific interest. Table 3 summarizes the main microbiological/probiotic/functional characteristics when comparing kefir and kombucha.
Further laboratory and clinical studies should be carried out on kefir and kombucha, to analyze other therapeutic and functional properties that have not been noticed. Fermented cultures/beverages such as kombucha and kefir are key opportunities for the food and clinic/medical fields.

Author Contributions

Conceptualization, T.A.d.A., P.P.L.G.T. and K.T.M.-G.; Data Curation, T.A.d.A., P.P.L.G.T., M.A.U.-G., J.D.S.G. and F.E.d.M.B.; Formal Analysis, K.T.M.-G., D.D.F. and J.A.V.C.; Funding Acquisition, K.T.M.-G. and J.A.V.C.; Investigation, T.A.d.A., P.P.L.G.T., J.D.S.G. and F.E.d.M.B.; Methodology, T.A.d.A., P.P.L.G.T., J.D.S.G., D.D.F. and F.E.d.M.B.; Project Administration, K.T.M.-G., M.A.U.-G. and J.A.V.C.; Resources, K.T.M.-G., J.A.V.C., J.D.S.G. and D.D.F.; Program, K.T.M.-G., J.A.V.C., J.D.S.G. and D.D.F.; Supervision, K.T.M.-G. and J.A.V.C.; Validation, K.T.M.-G., J.A.V.C., J.D.S.G. and D.D.F.; Writing—Original Draft Preparation, T.A.d.A., P.P.L.G.T., J.D.S.G. and K.T.M.-G.; Writing—Original Draft, T.A.d.A., P.P.L.G.T., J.D.S.G. and K.T.M.-G.; Writing—Review and Editing, K.T.M.-G., D.D.F., M.A.U.-G. and J.A.V.C. All authors have read and agreed to the published version of the manuscript.

Funding

The authors are grateful to the Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil (CNPq).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data available on request.

Acknowledgments

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil (Capes) and Universidade Federal da Bahia (UFBA).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Akkasheh, G.; Kashani-Poor, Z.; Tajabadi-Ebrahimi, M.; Jafari, P.; Akbari, H.; Taghizadeh, M.; Memarzadeh, M.R.; Asemi, Z.; Esmailzadeh, A. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, doubleblind, placebo-controlled trial. Nutrition 2016, 32, 315–320. [Google Scholar] [CrossRef] [PubMed]
  2. Beltrán-Barrientos, L.M.; Hernández-Mendoza, A.; Torres-Llanez, M.J.; González-Córdova, A.F.; Vallejo-Córdoba, B. Invited review: Fermented milk as antihypertensive functional food. J. Dairy Sci. 2016, 99, 4099–4110. [Google Scholar] [CrossRef] [PubMed]
  3. Bercik, P.; Collins, S.M.; Verdu, E.F. Microbes and the gut-brain axis. Neurogastroenterol. Motil. 2012, 24, 405–413. [Google Scholar] [CrossRef] [PubMed]
  4. da Silva, R.N.A.; Magalhães-Guedes, K.T.; de Oliveira Alves, R.M.; Souza, A.C.; Schwan, R.F.; Umsza-Guez, M.A. Yeast Diversity in Honey and Pollen Samples from Stingless Bees in the State of Bahia, Brazil: Use of the MALDI-TOF MS/Genbank Proteomic Technique. Microorganisms 2024, 12, 678. [Google Scholar] [CrossRef] [PubMed]
  5. Andrade, A.B.; Souza, C.C.A.; Grimaut, D.A.; Porto, E.A.; Silva, G.S.; Silva, J.S.J.; Santana, J.J.; Bastos, L.C.; Silva, R.N.A.; Anunciação, T.A.; et al. Kombucha-Based Cocoa Honey Beverage. World Appl. Sci. J. 2020, 38, 58–64. [Google Scholar]
  6. Bourrie, B.C.T.; Willing, B.P.; Cotter, P.D. The microbiota and health promoting characteristics of the fermented beverage kefir. Front. Microbiol. 2016, 7, 647. [Google Scholar] [CrossRef] [PubMed]
  7. Cevikbas, A.; Yemni, E.; Ezzedenn, F.W.; Yardimici, T.; Cevikbas, U.; Stohs, S.J. Antitumoural antibacterial and antifungal activities of kefir and kefir grain. Phytother. Res. 1994, 8, 78–82. [Google Scholar] [CrossRef]
  8. Maassen, C.B.; Van Holten-Neelen, C.; Balk, F.; Den Bak-Glashouwer, M.J.; Leer, R.J.; Laman, J.D.; Boersma, W.J.; Claassen, E. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 2000, 18, 2613–2623. [Google Scholar] [CrossRef] [PubMed]
  9. Tian, P.; O’Riordan, K.J.; Lee, Y.-K.; Wang, G.; Zhao, J.; Zhang, H.; Cryan, J.F.; Chen, W. Towards a psychobiotic therapy for depression: Bifidobacterium brevis CCFM1025 reverses chonic stress-induce depressive symptoms and gut microbial abnormalities in mice. Neurobiol. Stress 2020, 12, 100216. [Google Scholar] [CrossRef] [PubMed]
  10. Wang, Y.; Jiang, Y.; Deng, Y.; Yi, C.; Wang, Y.; Ding, M.; Liu, J.; Jin, X.; Shen, L.; He, Y.; et al. Probiotic Supplements: Hope or Hype? Front. Microbiol. 2020, 11, 160. [Google Scholar] [CrossRef]
  11. Cheng, L.-H.; Liu, Y.-W.; Wu, C.-C.; Wang, S.; Tsai, Y.-C. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders. J. Food Drug Analysis. 2019, 27, 632–648. [Google Scholar] [CrossRef] [PubMed]
  12. Magalhães-Guedes, K.T. The Dialogue between the Intestine-brain Axis: What is the Role of Probiotics? Asian Food Sci. J. 2020, 14, 23–27. [Google Scholar] [CrossRef]
  13. Magalhães-Guedes, K.T.; Anunciação, T.A.; Schwan, R.F. Kombucha and Kefir are foods of the 21st century: An opinion. J. Biotechnol. Biores 2019, 2, 1–2. [Google Scholar] [CrossRef]
  14. Magalhães-Guedes, K.T. Psychobiotic Therapy: Method to Reinforce the Immune System. Clin. Psychopharmacol. Neurosci. 2022, 20, 17. [Google Scholar] [CrossRef] [PubMed]
  15. Yerlikaya, O.; Akan, E.; Kinik, O. The metagenomic composition of water kefir microbiota. Int. J. Gastron. Food Sci. 2022, 30, 100621. [Google Scholar] [CrossRef]
  16. Tavares, P.P.L.G.; dos Anjos, E.A.; Nascimento, R.Q.; da Silva Cruz, L.F.; Lemos, P.V.F.; Druzian, J.I.; de Oliveira, T.T.B.; de Andrade, R.B.; da Costa Souza, A.L.; Magalhães-Guedes, K.T.; et al. Chemical, Microbiological and Sensory Viability of Low-Calorie, Dairy-Free Kefir Beverages from Tropical Mixed Fruit Juices. CYTA J. Food. 2021, 19, 457–464. [Google Scholar] [CrossRef]
  17. Patel, S.H.; Tan, J.P.; Boner, R.A.; Zhang, S.J.; Priour, S.; Lima, A.; Ngom-Bru, C.; Cotter, P.D.; Duboux, S. A temporal view of the water kefir microbiota and flavour attributes. Innov. Food Sci. Emerg. Technol. 2022, 80, 103084. [Google Scholar] [CrossRef]
  18. da CP Miguel, M.G.; Cardoso, P.G.; Magalhães, K.T.; Schwan, R.F. Profile of Microbial Communities Present in Tibico (Sugary Kefir) Grains from Different Brazilian States. World J. Microbiol. Biotechnol. 2011, 27, 1875–1884. [Google Scholar] [CrossRef]
  19. Randazzo, W.; Corona, O.; Guarcello, R.; Francesca, N.; Germanà, M.A.; Erten, H.; Moschetti, G.; Settanni, L. Development of New Non-Dairy Beverages from Mediterranean Fruit Juices Fermented with Water Kefir Microorganisms. Food Microbiol. 2016, 54, 40–51. [Google Scholar] [CrossRef]
  20. Moretti, A.F.; Moure, M.C.; Quiñoy, F.; Esposito, F.; Simonelli, N.; Medrano, M.; León-Peláez, Á. Water kefir, a fermented beverage containing probiotic microorganisms: From ancient and artisanal manufacture to industrialized and regulated commercialization. Future Foods 2022, 5, 100123. [Google Scholar] [CrossRef]
  21. Ganatsios, V.; Nigam, P.; Plessas, S.; Terpou, A. Kefir as a functional beverage gaining momentum towards its health promoting attributes. Beverages 2021, 7, 48. [Google Scholar] [CrossRef]
  22. Kumar, M.R.; Yeap, S.K.; Mohamad, N.E.; Abdullah, J.O.; Masarudin, M.J.; Khalid, M.; Leow, A.T.C.; Alitheen, N.B. Metagenomic and Phytochemical Analyses of Kefir Water and Its Subchronic Toxicity Study in BALB/c Mice. BMC Complement. Med. Ther. 2021, 21, 183. [Google Scholar] [CrossRef] [PubMed]
  23. Nascimento, R.Q.; Deamici, K.M.; Tavares, P.P.L.G.; de Andrade, R.B.; Guimarães, L.C.; Costa, J.A.V.; Magalhães-Guedes, K.T.; Druzian, J.I.; de Souza, C.O. Improving Water Kefir Nutritional Quality via Addition of Viable Spirulina Biomass. Bioresour. Technol. Rep. 2022, 17, 100914. [Google Scholar] [CrossRef]
  24. Magalhães-Guedes, K.T.; Barreto, I.T.; Tavares, P.P.L.G.; Bezerra, P.Q.M.; Silva, M.R.; Nunes, I.L.; Mamede, M.E.O.; Miguel, M.G.C.P.; Schwan, R.F. Effect of Kefir Biomass on Nutritional, Microbiological, and Sensory Properties of Mango-Based Popsicles. Int. Food. Res. J. 2020, 27, 536–545. Available online: https://www.proquest.com/docview/2437453316?fromopenview=true&pq-origsite=gscholar&sourcetype=Scholarly%20Journals (accessed on 20 January 2024).
  25. Viana, R.O.; Magalhães-Guedes, K.T.; Braga, R.A.; Dias, D.R.; Schwan, R.F. Fermentation Process for Production of Apple-Based Kefir Vinegar: Microbiological, Chemical and Sensory Analysis. Braz. J. Microbiol. 2017, 48, 592–601. [Google Scholar] [CrossRef] [PubMed]
  26. Destro, T.M.; Prates, D.D.F.; Watanabe, L.S.; Garcia, S.; Biz, G.; Spinosa, W.A. Organic Brown Sugar and Jaboticaba Pulp Influence on Water Kefir Fermentation. Cienc. Agrotec. 2019, 43, e005619. [Google Scholar] [CrossRef]
  27. Magalhães, K.T.; de Melo Pereira, G.V.; Campos, C.R.; Dragone, G.; Schwan, R.F. Brazilian Kefir: Structure, Microbial Communities and Chemical Composition. Braz. J. Microbiol. 2011, 42, 693–702. [Google Scholar] [CrossRef] [PubMed]
  28. Puerari, C.; Magalhães, K.T.; Schwan, R.F. New Cocoa Pulp-Based Kefir Beverages: Microbiological, Chemical Composition and Sensory Analysis. Food Res. Int. 2012, 48, 100212. [Google Scholar] [CrossRef]
  29. Tzavaras, D.; Papadelli, M.; Ntaikou, I. From Milk Kefir to Water Kefir: Assessment of Fermentation Processes, Microbial Changes and Evaluation of the Produced Beverages. Fermentation 2022, 8, 135. [Google Scholar] [CrossRef]
  30. Agarbati, A.; Ciani, M.; Canonico, L.; Galli, E.; Comitini, F. Exploitation of Yeasts with Probiotic Traits for Kefir Production: Effectiveness of the Microbial Consortium. Fermentation 2022, 8, 9. [Google Scholar] [CrossRef]
  31. Apalowo, O.E.; Adegoye, G.A.; Mbogori, T.; Kandiah, J.; Obuotor, T.M. Nutritional Characteristics, Health Impact, and Applications of Kefir. Foods 2024, 13, 1026. [Google Scholar] [CrossRef] [PubMed]
  32. Wang, B.; Rutherfurd-Markwick, K.; Zhang, X.X.; Mutukumira, A.N. Kombucha: Production and microbiological research. Foods 2022, 11, 3456. [Google Scholar] [CrossRef] [PubMed]
  33. Villarreal-Soto, S.A.; Beaufort, S.; Bouajila, J.; Souchard, J.P.; Taillandier, P. Understanding kombucha tea fermentation: A review. J. Food Sci. 2018, 83, 580–588. [Google Scholar] [CrossRef] [PubMed]
  34. de Oliveira, I.A.C.L.; Rolim, V.A.O.; Gaspar, R.P.L.; Rossini, D.Q.; de Souza, R.; Bogsan, C.S.B. The technological perspectives of kombucha and its implications for production. Fermentation 2022, 8, 185. [Google Scholar] [CrossRef]
  35. Jafari, R.; Naghavi, N.S.; Khosravi-Darani, K.; Doudi, M.; Shahanipour, K. Kombucha microbial starter with enhanced production of antioxidant compounds and invertase. Biocatal. Agric. Biotechnol. 2020, 29, 101789. [Google Scholar] [CrossRef]
  36. Ferreira, J.E.V.; Pinheiro, M.T.S.; Santos, W.R.S.; Maia, R.S. Graphical representation of chemical periodicity of main elements through boxplot. Educación. Quím. 2016, 27, 209–216. [Google Scholar] [CrossRef]
  37. Nelson, L.S. Evaluating Overlapping Confidence Intervals. J. Qual. Technol. 1989, 21, 140–141. Available online: https://www.gapimprove.org/_files/ugd/cd8b34_9285d64315ed44deaec0869c49cad917.pdf?index=true (accessed on 20 January 2024). [CrossRef]
  38. Ferreira, I.; de Sousa Melo, D.; Santos, M.S.; Dias, D.R.; de Souza, C.O.; Favaro-Trindade, C.S.; Pinho, L.S.; de Castro Almeida, R.C.; Magalhães-Guedes, K.T.; Schwan, R.F. Non-Lactic Probiotic Beverage Enriched with Microencapsulated Red Propolis: Microorganism Viability, Physicochemical Characteristics, and Sensory Perception. Fermentation 2023, 9, 234. [Google Scholar] [CrossRef]
  39. Tavares, P.P.L.G.; Mamona, C.T.P.; Nascimento, R.Q.; dos Anjos, E.A.; de Souza, C.O.; Almeida, R.C.d.C.; Mamede, M.E.d.O.; Magalhães-Guedes, K.T. Non-Conventional Sucrose-Based Substrates: Development of Non-Dairy Kefir Beverages with Probiotic Potential. Fermentation 2023, 9, 384. [Google Scholar] [CrossRef]
  40. Xia, X.; Dai, Y.; Wu, H.; Liu, X.; Wang, Y.; Yin, L.; Wang, Z.; Li, X.; Zhou, J. Kombucha fermentation enhances the health-promoting properties of soymilk beverage. J. Funct. Food 2019, 62, 103549. [Google Scholar] [CrossRef]
  41. Jayabalan, R.; Chen, P.N.; Hsieh, Y.S.; Prabhakaran, K.; Pitchai, P.; Marimuthu, S.; Thangaraj, P.; Swaminathan, K.; Yun, S.E. Effect of solvent fractions of kombucha tea on viability and invasiveness of cancer cells—Characterization of dimethyl 2-(2-hydroxy-2-methoxypropylidine) malonate and vitexin. Indian J. Biotechnol. 2011, 10, 75–82. Available online: https://research.kombuchabrewers.org/wp-content/uploads/kk-research-files/effect-of-solvent-fractions-of-kombucha-tea-on-viability-and-invasiveness-of-cancer-cells-characteri.pdf (accessed on 20 January 2024).
  42. Yapar, K.; Cavusoglu, K.; Oruc, E.; Yalcin, E. Protective effect of kombucha mushroom (KM) tea on phenol-induced cytotoxicity in albino mice. J. Environ. Biol. 2010, 31, 615–621. Available online: https://pubmed.ncbi.nlm.nih.gov/21387911/ (accessed on 20 January 2024). [PubMed]
  43. Coelho, R.M.D.; de Almeida, A.L.; do Amaral, R.Q.G.; da Mota, R.N.; de Sousa, P.H.M. Kombucha: Review. Int. J. Gastron. Food Sci. 2020, 22, 100272. [Google Scholar] [CrossRef]
  44. Antolak, H.; Piechota, D.; Kucharska, A. Kombucha tea-a double power of bioactive compounds from tea and symbiotic culture of bacteria and yeasts (SCOBY). Antioxidants 2012, 10, 1541. [Google Scholar] [CrossRef] [PubMed]
  45. John, S.M.; Deeseenthum, S. Properties and benefits of kefir-a review. J. Sci. Technol. 2015, 37, 275–282. Available online: https://www.semanticscholar.org/paper/Properties-and-benefits-of-kefir-A-review-John-Deeseenthum/77c84dbf6e579315c516fd13ed282ffcb0f51e26 (accessed on 20 January 2024).
  46. Reis, S.A.; Conceição, L.L.; Dias, M.M.; Siqueira, N.P.; Rosa, D.D.; Oliveira, L.L.; Matta, S.L.P.; Peluzio, M.C.G. Kefir reduces the incidence of pre-neoplastic lesions in an animal model for colorectal cancer. J. Funct. Foods 2019, 53, 1–6. [Google Scholar] [CrossRef]
  47. Liu, J.R.; Wang, S.Y.; Lin, Y.Y.; Lin, C.W. Antitumor activity of milk kefir and soy milk kefir in tumor-bearing mice. Nutr. Cancer 2002, 44, 183–187. [Google Scholar] [CrossRef] [PubMed]
  48. Furukawa, N.; Matsuoka, A.; Yamanaka, Y. Effects of orally administered yogurt and kefir on tumor growth in mice. Nipp. Eiyo Shokuryo Gakkaishi 1990, 43, 450–453. [Google Scholar] [CrossRef]
  49. Lopitz-Otsoa, F.; Rementeria, A.; Elguezabal, N.; Garaizar, J. Kefir: A symbiotic yeasts-bacteria community with alleged healthy capabilities. Rev. Iberoam. Micol. 2006, 23, 67–74. [Google Scholar] [CrossRef] [PubMed]
  50. Rattray, F.P.; O’Connell, M.J. Kefir. In Encyclopedia of Dairy Sciences, 2nd ed.; Fuquay, J.W., Fox, P.F., McSweeney, P.L.H., Eds.; Elsevier Ltd.: Oxford, UK, 2011; Volume 2, pp. 518–524. [Google Scholar]
  51. Petra, A.I.; Panagiotidou, S.; Hatziagelaki, E.; Stewart, J.M.; Conti, P.; Theoharides, T.C. Gut-microbiota-brain axis and effect on neuropsychiatric disorders with suspected immune dysregulation. Clin. Ther. 2015, 37, 984–995. [Google Scholar] [CrossRef] [PubMed]
  52. Sirirat, D.; Jelena, P. Bacterial inhibition and antioxidant activity of kefir produced from Thai Jasmine rice milk. Biotechnology 2010, 9, 332–337. [Google Scholar] [CrossRef]
  53. Gülmez, M.; Güven, A. Survival of Escherichia coli O157:H7, Listeria monocytogenes 4b and Yersinia enterocolitica O3 in ayran and modified kefir as pre- and postfermentation contaminant. Vet. Med. Czech. 2003, 48, 126–132. [Google Scholar] [CrossRef] [PubMed]
  54. Kwon, C.S.; Park, M.Y.; Cho, J.S.; Choi, S.T.; Chang, D.S. Identification of effective microorganisms from kefir fermented milk. Food Sci. Biotechnol. 2003, 12, 476–479. Available online: https://www.semanticscholar.org/paper/Identification-of-Effective-Microorganisms-from-Kwon-Park/782d5e0a480b623e6b504a729614b9576bef4595 (accessed on 20 January 2024).
  55. Rodrigues, K.L.; Caputo, L.R.G.; Carvalho, J.C.T.; Evangelista, J.; Schneedorf, J.M. Antimicrobial and healing activity of kefir and kefiran extract. Int. J. Antimicrob. Agents 2005, 25, 404–408. [Google Scholar] [CrossRef] [PubMed]
  56. Zubaidah, E.; Iastika, A.R.; Widyaningsih, T.D.; Febrianto, K. Immunomodulatory Activity of Black Tea Kombucha (Camellia sinensis) and Arabica Coffee Leaves Tea Kombucha (Coffee arabica) for Salmonella typhi-infected mice. IOP Conf. Ser. Earth Environ. Sci. 2021, 733, 012128. [Google Scholar] [CrossRef]
  57. Sknepnek, A.; Tomić, S.; Miletić, D.; Lević, S.; Čolić, M.; Nedović, V.; Nikšić, M. Fermentation characteristics of novel Coriolus versicolor and Lentinus edodes kombucha beverages and immunomodulatory potential of their polysaccharide extracts. Food Chem. 2021, 342, 128344. [Google Scholar] [CrossRef] [PubMed]
  58. Vázquez-Cabral, B.D.; Larrosa-Pérez, M.; Gallegos-Infante, J.A.; Moreno-Jiménez, M.R.; González-Laredo, R.F.; Rutiaga-Quiñones, J.G.; Gamboa-Gómez, C.I.; Rocha-Guzmán, N.E. Oak kombucha protects against oxidative stress and inflammatory processes. Chem. Biol. Interact. 2017, 272, 1–9. [Google Scholar] [CrossRef] [PubMed]
  59. Ziska, R.; Agustina, A.; Supriadi. Cytotoxic Activity Assay of N-Hexane Extract of Solanum nigrum L. Fruits Fermented by Kombucha against MCF-7 Breast Cancer Cell Line. J. Phys. Conf. Ser. 2019, 1338, 012027. [Google Scholar] [CrossRef]
  60. Ghodousi Dehnavi, E.; Arjmand, M.; Haji Hosseini, R.; Zamani, Z.; Nasri, S. Evaluation of Anti-Proliferative and Anti-Effects of Kombucha Tea Solvent Fraction on Colorectal Cancer Cell Line (HT-29). J. Anim. Biol. 2020, 13, 85–100. [Google Scholar]
  61. Kaewkod, T.; Bovonsombut, S.; Tragoolpua, Y. Efficacy of Kombucha Obtained from Green, Oolong, and Black Teas on Inhibition of Pathogenic Bacteria, Antioxidation, and Toxicity on Colorectal Cancer Cell Line. Microorganisms 2019, 7, 700. [Google Scholar] [CrossRef] [PubMed]
  62. Kumar, V.K.; Joshi, V.K. Kombucha: Technology, Microbiology, Production, Composition and Therapeutic Value. Int. J. Food. Ferment. Technol. 2016, 6, 13–24. [Google Scholar] [CrossRef]
  63. Laurenson, S.; Villamizar, L.; Ritchie, W.; Scott, S.; Mackay, M. Novel use of Kombucha consortium to reduce Escherichia coli in dairy shed effluent. J. Sci. Food Agric. 2021, 101, 6143. [Google Scholar] [CrossRef] [PubMed]
  64. Santos Júnior, R.J.; Batista, R.A.; Rodrigues, S.A.; Xavier Filho, L.; Lima, A.S. Antimicrobial Activity of Broth Fermented with Kombucha Colonies. Microbiol. Biochem. Technol. 2009, 1, 72–78. [Google Scholar] [CrossRef]
  65. Battikh, H.; Chaieb, K.; Bakhrouf, A.; Ammar, E. Antibacterial and antifungal activities of black and green Kombucha teas. J. Food Biochem. 2012, 37, 231–236. [Google Scholar] [CrossRef]
  66. Atalar, I.; Dervisoglu, M. Optimization of spray drying process parameters for kefir powder using response surface methodology. LWT Food Scien. Technol. 2015, 60, 751–757. [Google Scholar] [CrossRef]
  67. Teijeiro, M.; Pérez, P.F.; De Antoni, G.L.; Golowczyc, M.A. Suitability of kefir powder production using spray drying. Food Res. Int. 2018, 112, 169–174. [Google Scholar] [CrossRef] [PubMed]
  68. Yilmaz, M.T.; Taylan, O.; Karakas, C.Y.; Dertli, E. An alternative way to encapsulate probiotics within electrospun alginate nanofibers as monitored under simulated gastrointestinal conditions and in kefir. Carbohydr. Polym. 2020, 244, 116447. [Google Scholar] [CrossRef] [PubMed]
  69. Jayabalan, R.; Subathradevi, P.; Marimuthu, S.; Sathishkumar, M.; Swaminathan, K. Changes in free-radical scavenging ability of kombucha tea during fermentation. Food Chem. 2008, 109, 227–234. [Google Scholar] [CrossRef] [PubMed]
  70. Roby, B.H.M.; Muhialdin, B.J.; Abadl, M.M.T.; Nor, N.A.M.; Marzlan, A.A.; Lim, S.A.H.; Mustapha, N.A.; Hussin, A.S.M. Physical properties, storage stability, and consumer acceptability for sourdough bread produced using encapsulated kombucha sourdough starter culture. Integr. Food Sci. 2020, 85, 2286–2295. [Google Scholar] [CrossRef] [PubMed]
  71. Pillaia, M.M.; Tranb, H.N.; Sathishkumara, G.; Manimekalaia, K.; Yoonb, J.H.; Limb, D.Y.; Nohb, I.; Bhattacharyya, A. Symbiotic culture of nanocellulose pellicle: A potential matrix for 3D bioprinting. Mater. Sci. Eng. C 2021, 119, 111552. [Google Scholar] [CrossRef] [PubMed]
  72. Enikeev, R. Development of a new method for determination of exopolysaccharide quantity in fermented milk products and its application in technology of kefir production. Food Chem. 2012, 134, 2437–2441. [Google Scholar] [CrossRef] [PubMed]
  73. Jayabalan, R.; Malbaša, R.V.; Lončar, E.S.; Vitas, J.S.; Sathishkumar, M. A review on kombucha tea—Microbiology, composition, fermentation, beneficial effects, toxicity, and tea fungus. Compr. Rev. Food Sci. Food Saf. 2014, 13, 538–550. [Google Scholar] [CrossRef] [PubMed]
  74. Chakravorty, S.; Bhattacharya, S.; Chatzinotas, A.; Chakraborty, W.; Bhattacharya, D.; Gachhui, R. Kombucha tea fermentation: Microbial and biochemical dynamics. Int. J. Food Microbiol. 2016, 220, 63–72. [Google Scholar] [CrossRef] [PubMed]
  75. Weschenfelder, S.; Pereira, G.M.; Carvalho, H.H.C.; Wiest, J.M. Caracterização físico-química e sensorial de kefir tradicional e derivados. Arq. Bras. Med. Veterinária Zootec. 2011, 63, 473–480. [Google Scholar] [CrossRef]
  76. Paramithiotis, S.; Patra, J.K.; Kotseridis, Y.; Dimopoulou, M. Fermented Beverages Revisited: From Terroir to Customized Functional Products. Fermentation 2024, 10, 57. [Google Scholar] [CrossRef]
  77. Chong, A.Q.; Lau, S.W.; Chin, N.L.; Talib, R.A.; Basha, R.K. Fermented Beverage Benefits: A Comprehensive Review and Comparison of Kombucha and Kefir Microbiome. Microorganisms 2023, 11, 1344. [Google Scholar] [CrossRef] [PubMed]
  78. Mouguech, N.; Taillandier, P.; Bouajila, J.; Basseguy, R.; Romdhane, M.; Etteyeb, N. Influence of Galvanized Steel on Kombucha Fermentation: Weight Loss Measurements, Scanning Electron Microscopy Analysis, Corrosion Activity, and Phytochemical Study. Fermentation 2024, 10, 159. [Google Scholar] [CrossRef]
  79. Marquez, A.; Russo, M.; Tomei, C.; Castellano, P.; Puglisi, E.; Medina, R.; Gauffin-Cano, P. Effects of Fermented Goat Milk on Adiposity and Gut Microbiota in a Diet-Induced Obesity Murine Model. Fermentation 2024, 10, 155. [Google Scholar] [CrossRef]
  80. Dahiya, D.; Nigam, P.S. The Gut Microbiota Influenced by the Intake of Probiotics and Functional Foods with Prebiotics Can Sustain Wellness and Alleviate Certain Ailments like Gut-Inflammation and Colon-Cancer. Microorganisms 2022, 10, 665. [Google Scholar] [CrossRef] [PubMed]
  81. Elcheninov, A.G.; Zayulina, K.S.; Klyukina, A.A.; Kremneva, M.K.; Kublanov, I.V.; Kochetkova, T.V. Metagenomic Insights into the Taxonomic and Functional Features of Traditional Fermented Milk Products from Russia. Microorganisms 2024, 12, 16. [Google Scholar] [CrossRef] [PubMed]
  82. Kruk, M.; Trząskowska, M.; Ścibisz, I.; Pokorski, P. Application of the “SCOBY” and Kombucha Tea for the Production of Fermented Milk Drinks. Microorganisms 2021, 9, 123. [Google Scholar] [CrossRef] [PubMed]
  83. Harrison, K.; Curtin, C. Microbial Composition of SCOBY Starter Cultures Used by Commercial Kombucha Brewers in North America. Microorganisms 2021, 9, 1060. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Distribution of number of papers by keywords searched. A group—Keyword in English (functional kombucha beverage); in Spanish (bebida kombucha funcional); in Portuguese (bebida functional de kombucha). B group—Keyword in English/Spanish/Portuguese (kefiran). C group—Keyword in English (functional beverage); in Spanish/Portuguese (bebida funcional). D group—Keyword in English (probiotics microorganisms); in Spanish (microorganismos probióticos); in Portuguese (micro-organismos probióticos). E group—Keyword in English (functional kefir beverage); in Spanish (bebida de kéfir functional); in Portuguese (bebida functional de kefir). F group—Keyword in English (kombucha probiotic); in Spanish (probiótico kombucha); in Portuguese (kombucha probiótico). G group—Keyword in English (kefir probiotic); in Spanish (probiótico kefir); in Portuguese (kefir probiótico). H group—Keyword in English (non-dairy probiotic beverage); in Spanish (bebida probiótica no láctea); in Portuguese (bebida probiótica não láctea). I group—Keyword in English (symbiotic culture); in Spanish (cultivo simbiótico); in Portuguese (cultura simbiótica). Red cross (+) are outliers (discrepant values in relation to the other analyzed values).
Figure 1. Distribution of number of papers by keywords searched. A group—Keyword in English (functional kombucha beverage); in Spanish (bebida kombucha funcional); in Portuguese (bebida functional de kombucha). B group—Keyword in English/Spanish/Portuguese (kefiran). C group—Keyword in English (functional beverage); in Spanish/Portuguese (bebida funcional). D group—Keyword in English (probiotics microorganisms); in Spanish (microorganismos probióticos); in Portuguese (micro-organismos probióticos). E group—Keyword in English (functional kefir beverage); in Spanish (bebida de kéfir functional); in Portuguese (bebida functional de kefir). F group—Keyword in English (kombucha probiotic); in Spanish (probiótico kombucha); in Portuguese (kombucha probiótico). G group—Keyword in English (kefir probiotic); in Spanish (probiótico kefir); in Portuguese (kefir probiótico). H group—Keyword in English (non-dairy probiotic beverage); in Spanish (bebida probiótica no láctea); in Portuguese (bebida probiótica não láctea). I group—Keyword in English (symbiotic culture); in Spanish (cultivo simbiótico); in Portuguese (cultura simbiótica). Red cross (+) are outliers (discrepant values in relation to the other analyzed values).
Microorganisms 12 01127 g001
Figure 2. Number of papers by database searched. *BVS—Biblioteca Virtual de Saúde (Virtual Health Library). Red cross (+) are outliers (discrepant values in relation to the other analyzed values).
Figure 2. Number of papers by database searched. *BVS—Biblioteca Virtual de Saúde (Virtual Health Library). Red cross (+) are outliers (discrepant values in relation to the other analyzed values).
Microorganisms 12 01127 g002
Figure 3. Distribution of number of papers by languages searched. Red cross (+) are outliers (discrepant values in relation to the other analyzed values).
Figure 3. Distribution of number of papers by languages searched. Red cross (+) are outliers (discrepant values in relation to the other analyzed values).
Microorganisms 12 01127 g003
Figure 4. Bacteria/yeast genera present in kefir grains and kefir-based beverage. Original and unpublished figure (authors’ archive).
Figure 4. Bacteria/yeast genera present in kefir grains and kefir-based beverage. Original and unpublished figure (authors’ archive).
Microorganisms 12 01127 g004
Figure 5. Production of kefir beverages. Kefir grains (1) are added to substratum and left at room temperature for fermentation for 18–24 h (2), the substratum is then fermented forming the kefir beverage (3), after which they are filtered, (4) and ready to start another cycle. The fermented beverage that results from step 3 is appropriate for consumption. Original and unpublished figure (authors’ archive).
Figure 5. Production of kefir beverages. Kefir grains (1) are added to substratum and left at room temperature for fermentation for 18–24 h (2), the substratum is then fermented forming the kefir beverage (3), after which they are filtered, (4) and ready to start another cycle. The fermented beverage that results from step 3 is appropriate for consumption. Original and unpublished figure (authors’ archive).
Microorganisms 12 01127 g005
Figure 6. Bacteria/yeast genera present in kombucha SCOBY and kombucha-based beverage. Original and unpublished figure (authors’ archive).
Figure 6. Bacteria/yeast genera present in kombucha SCOBY and kombucha-based beverage. Original and unpublished figure (authors’ archive).
Microorganisms 12 01127 g006
Figure 7. Kombucha production. SCOBY (1) are added to Camelia sinensis tea and are left to stand at room temperature for fermentation 168 h (2), after which the beverage can be re-fermented in another substrate (fruit, vegetable pulps) or be consumed (3). Original and unpublished figure (authors’ archive).
Figure 7. Kombucha production. SCOBY (1) are added to Camelia sinensis tea and are left to stand at room temperature for fermentation 168 h (2), after which the beverage can be re-fermented in another substrate (fruit, vegetable pulps) or be consumed (3). Original and unpublished figure (authors’ archive).
Microorganisms 12 01127 g007
Table 1. Quantitative analysis of scientific articles until January 2024 in the Database Google Scholar.
Table 1. Quantitative analysis of scientific articles until January 2024 in the Database Google Scholar.
LanguagesKey WordsNumber of Articles
Englishprobiotics microorganisms993,000
kefir probiotic779,000
kombucha probiotic707,000
non-dairy probiotic beverage747,600
functional beverage509,000
functional kefir beverage457,600
functional kombucha beverage342,500
symbiotic culture132,300
kefiran7321
Spanishmicroorganismos probióticos416,500
kéfir probiótico365,000
probiótico kombucha178,988
bebida probiótica no láctea116,900
bebida funcional109,000
bebida de kéfir funcional93,800
bebida kombucha funcional63,702
cultivo simbiótico42,810
kefiran3000
Portuguesemicro-organismos probióticos116,800
kefir probiótico93,510
kombucha probiótico47,751
bebida probiótica não láctea33,200
bebida funcional 27,200
bebida funcional de kefir15,500
bebida funcional de kombucha1292
cultura simbiótica1270
kefiran1300
Table 2. Quantitative analysis of scientific articles until January 2024 in the Database Science Direct.
Table 2. Quantitative analysis of scientific articles until January 2024 in the Database Science Direct.
LanguagesKey WordsNumber of Articles
Englishprobiotics microorganisms19,184
kefir probiotic2168
kombucha probiotic564
non-dairy probiotic beverage3570
functional beverage6923
functional kefir beverage2517
functional kombucha beverage459
symbiotic culture31,111
kefiran538
Spanishmicroorganismos probióticos272
kéfir probiótico13
probiótico kombucha39
bebida probiótica no láctea0
bebida funcional921
bebida de kéfir funcional0
bebida kombucha funcional0
cultivo simbiótico33
kefiran23
Portuguesemicro-organismos probióticos0
kefir probiótico0
kombucha probiótico0
bebida probiótica não láctea0
bebida funcional 0
bebida funcional de kefir0
bebida funcional de kombucha0
cultura simbiótica0
kefiran0
Table 3. Main microbiological/probiotic/functional characteristics when comparing kefir and kombucha.
Table 3. Main microbiological/probiotic/functional characteristics when comparing kefir and kombucha.
KefirKombucha
OriginsNorthern Caucasian mountains [49,70,71,72]. East Asia [69,73,74].
Principle characteristicsKefir is a fermented beverage and effervescent. The fermentation process is conducted by the kefiran polysaccharide matrix [6,7,13,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,39,45,46,47,48,49,50,52,53,54,55,66,67,68,72,75,76,77,78,79,80,81]. Kombucha is a fermented beverage produced by the fermentation of black, oolong or green tea, varieties of Camellia sinensis tea, with sugar and a symbiotic microorganism culture known as SCOBY (Symbiotic Culture of Bacteria and Yeast) [5,13,32,33,34,35,40,41,42,43,44,56,57,58,59,60,61,62,63,64,65,69,70,71,73,76,77,78,79,80,82,83].
Probiotic microbiomaLactobacillus spp., Acetobacter spp., Bifidobacterium spp., and others; and yeast species as Saccharomyces spp., Candida spp., Kluyveromyces spp., [6,7,13,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,39,45,46,47,48,49,50,52,53,54,55,66,67,68,72].Acetobacter spp., Gluconobacter spp., Komagataeibacter spp., Lactococcus spp., Lactobacillus spp., Brettanomyces spp., Kloeckera spp., Saccharomyces spp., Saccharomycodes spp., Schizosaccharomyces spp., Torulaspora spp., and Zygosaccharomyces spp. [5,13,32,33,34,35,40,41,42,43,44,56,57,58,59,60,61,62,63,64,65,69,70,73].
Diet-kefir/kombucha against ObesityKefir on adiposity and gut microbiota [77,78,79].Kombucha on adiposity and gut microbiota [77,78,79].
Tradicional preparation of the beveragesKefir beverage is prepared using pasteurized or UHT (Ultra-high-temperature processing) treated milk and the fermentation occurs for 24–48 h [27].Kombucha beverage is fermented for a period of 7–12 days at room temperature in static fermentation [74].
Immunomodulatory activityKombucha tea/beverage was used as an immunomodulating agent in mice infected with Salmonella typhi [56]. This showed inhibitory effects on Th2 and IL-10 suggesting that the consumption of these beverages may be beneficial for the prevention and treatment of allergic reactions, asthma, or atopic dermatitis [57]. Kefir increases the phagocytic activity of macrophages, stimulating the immune system. Kefir also influences the activity of host immune cells, regulation of inflammation, barrier function and cell-to-cell signaling [10].
Antitumor/anticarcinogenic activityFeeding with kefir grain was effective in inhibiting lung carcinoma when administered for 9 days after tumor inoculation in mice [48]. Another study demonstrated that kefir beverages (soybeans and milk) resulted in ~65% and ~71% inhibition of tumor growth (sarcoma-180) compared to controls [47] The gut microbiota influenced by kefir probiotic intake may support well-being and alleviate intestinal inflammation and colon cancer [80].In a study with the HT-29 colon cancer strain, kombucha was capable of inhibition of cell growth, DNA fragmentation, cell death apoptosis and antiproliferative activity [60]. Kombucha prepared from green tea and black tea has shown toxicity in Caco-2 colorectal cancer cells [61]. The gut microbiota influenced by kombucha probiotic intake may support well-being and alleviate intestinal inflammation and colon cancer [80].
Antimicrobial activityKefir contains antimicrobial substances, such as lactic acid, acetic acid and H2O2, which have bactericidal and bacteriostatic effects [75]. Kefir showed microbial inhibition activity against Staphylococcus aureus, Pseudomonas fluorescens, Escherichia coli and Bacillus subtilis [52].Kombucha was highly effective in reducing the number of Eschericha coli colony-forming units (CFU) to undetectable levels [63]. Pathogenic bacteria: Escherichia coli O157:H7, Shigella dysenteriae, Salmonella Typhi and Vibrio cholera were inhibited by kombucha [61].
Manipulation and new formulations The production of kefir powder using spray drying helps the survival of kefir probiotics microorganisms in the gastrointestinal environment [66,67].The sustainable microbial biopolymer kombucha shows the potential to be used as a bioink for 3D bioprinting [71]. Production of fermented dough bread uses a starter culture of encapsulated kombucha without addition of baker’s yeast [70].
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

da Anunciação, T.A.; Guedes, J.D.S.; Tavares, P.P.L.G.; de Melo Borges, F.E.; Ferreira, D.D.; Costa, J.A.V.; Umsza-Guez, M.A.; Magalhães-Guedes, K.T. Biological Significance of Probiotic Microorganisms from Kefir and Kombucha: A Review. Microorganisms 2024, 12, 1127. https://doi.org/10.3390/microorganisms12061127

AMA Style

da Anunciação TA, Guedes JDS, Tavares PPLG, de Melo Borges FE, Ferreira DD, Costa JAV, Umsza-Guez MA, Magalhães-Guedes KT. Biological Significance of Probiotic Microorganisms from Kefir and Kombucha: A Review. Microorganisms. 2024; 12(6):1127. https://doi.org/10.3390/microorganisms12061127

Chicago/Turabian Style

da Anunciação, Talita Andrade, Juan Diego Silva Guedes, Pedro Paulo Lordelo Guimarães Tavares, Fernando Elias de Melo Borges, Danton Diego Ferreira, Jorge Alberto Vieira Costa, Marcelo Andrés Umsza-Guez, and Karina Teixeira Magalhães-Guedes. 2024. "Biological Significance of Probiotic Microorganisms from Kefir and Kombucha: A Review" Microorganisms 12, no. 6: 1127. https://doi.org/10.3390/microorganisms12061127

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop